11 results
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... and incidental DVT ... or PE in cancer ... single subsegmental PE ... #Cancer #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... DVT = deep vein ... thrombosis; PE = ... #Cancer #Algorithm
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... for First Time DVT ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Thromboembolism Treatment ... Algorithm Branch ... #Management #VTE ... #DVT #Algorithm ... #Hematology #Anticoagulation
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... #PE #Pulmonary # ... Embolism #Treatment ... #Algorithm #management ... #hematology #VTE
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
first DVT or PE ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #hematology #length ... #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... Isolated distal DVT ... or PE - High ... therapy - Second VTE
Portal Vein Thrombosis (PVT) Treatment Algorithm
 - If concern for ischemic: anti-coag+multidisciplinary care
 - W/o cirrhosis+recent
) Treatment Algorithm ... - If concern ... for ischemic: anti-coag ... case-by-cased treatment ... #Algorithm #hepatology
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

https://www.nejm.org/doi/full/10.1056/NEJMoa1711948

Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Edoxaban for the Treatment ... of Cancer-Associated ... respect to recurrent VTE ... VisualAbstract #DVT ... #PE
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... PE, first trimester ... • Treatment is ... • Treatment algorithms ... Thrombocythemia #ET #hematology